Biomarker A+T−: is this Alzheimer’s disease or not? A combined CSF and pathology study
Abstract The biological definition of Alzheimer’s disease using CSF biomarkers requires abnormal levels of both amyloid (A) and tau (T). However, biomarkers and corresponding cutoffs may not always reflect the presence or absence of pathology. Previous studies suggest that up to 32% of individuals w...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | angličtina |
| Vydáno: |
2022
|
| On-line přístup: | https://doi.org/10.1093/brain/awac158 https://academic.oup.com/brain/article-pdf/146/3/1166/49356410/awac158.pdf |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|